Colgate-Palmolive Company (CL) trades at a trailing P/E of 32.1, forward P/E of 21.8. Trailing earnings yield is 3.12%, forward earnings yield 4.58%. PEG 0.47 (Peter Lynch undervalued ≤1.0). Graham Number is $5.20.
Criteria proven by this page:
Overall SharesGrow Score: 60/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 23.9 | 0.30 | -240.16 | 3.84 | 2.58% |
| 2017 | 32.9 | -2.05 | -1,108.86 | 4.31 | 2.30% |
| 2018 | 21.6 | 1.08 | -508.02 | 3.33 | 3.07% |
| 2019 | 25.0 | 0.00 | 505.47 | 3.77 | 2.73% |
| 2020 | 27.2 | 1.92 | 98.61 | 4.45 | 2.05% |
| 2021 | 33.3 | -1.78 | 118.41 | 4.14 | 2.33% |
| 2022 | 36.9 | -2.20 | 164.34 | 3.67 | 2.57% |
| 2023 | 28.7 | 0.94 | 108.30 | 3.39 | 2.65% |
| 2024 | 25.7 | 0.95 | 350.65 | 3.70 | 2.41% |
| 2025 | 30.0 | -1.19 | 1,183.40 | 3.14 | 2.85% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $2.72 | $15.2B | $2.44B | 16.1% |
| 2017 | $2.28 | $15.45B | $2.02B | 13.1% |
| 2018 | $2.75 | $15.54B | $2.4B | 15.4% |
| 2019 | $2.75 | $15.69B | $2.37B | 15.1% |
| 2020 | $3.14 | $16.47B | $2.7B | 16.4% |
| 2021 | $2.55 | $17.42B | $2.17B | 12.4% |
| 2022 | $2.13 | $17.97B | $1.79B | 9.9% |
| 2023 | $2.77 | $19.46B | $2.3B | 11.8% |
| 2024 | $3.51 | $20.1B | $2.89B | 14.4% |
| 2025 | $2.63 | $20.38B | $2.13B | 10.5% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $3.87 | $3.83 – $3.92 | $21.3B | $21.08B – $21.48B | 11 |
| 2027 | $4.12 | $4.08 – $4.21 | $22.03B | $21.76B – $22.34B | 11 |
| 2028 | $4.43 | $4.24 – $4.53 | $22.86B | $22.82B – $22.9B | 3 |
| 2029 | $4.68 | $4.60 – $4.76 | $23.59B | $23.29B – $23.91B | 1 |
| 2030 | $4.92 | $4.84 – $5.01 | $24.17B | $23.86B – $24.5B | 1 |
